Viewing Study NCT06012695


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2025-12-27 @ 3:01 AM
Study NCT ID: NCT06012695
Status: RECRUITING
Last Update Posted: 2024-11-14
First Post: 2023-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
Sponsor: Novelwise Pharmaceutical Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module